Gilead Sciences, Inc. (GILD): net debt to ebitda, 10 filed years
Net debt/EBITDA at Gilead Sciences, Inc. was 1.73x in FY2025, the newest filed year. Across the 8 computed years from FY2018 it ranged from 1.17x (FY2018) to 8.48x (FY2024), with a median of 2.56x.
Tonight's figure on the company page: 1.73x, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | Net debt/EBITDA | Read from |
|---|---|---|
| FY2016 The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read. | n/a | 10-K, filed 2017-02-27 |
| FY2017 The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read. | n/a | 10-K, filed 2018-02-27 |
| FY2018 | 1.17x | 10-K, filed 2019-02-26 |
| FY2019 | 3.01x | 10-K, filed 2020-02-25 |
| FY2020 | 5.99x | 10-K, filed 2021-02-25 |
| FY2021 | 2.14x | 10-K, filed 2022-02-23 |
| FY2022 | 2.67x | 10-K, filed 2023-02-22 |
| FY2023 | 2.46x | 10-K, filed 2024-02-23 |
| FY2024 | 8.48x | 10-K, filed 2025-02-28 |
| FY2025 | 1.73x | 10-K, filed 2026-02-24 |
How each year is computed
(Total debt - cash) / EBITDA
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.